Arbutus Biopharma (ABUS) Other Non-Current Assets (2019 - 2025)
Historic Other Non-Current Assets for Arbutus Biopharma (ABUS) over the last 7 years, with Q3 2025 value amounting to $131000.0.
- Arbutus Biopharma's Other Non-Current Assets changed N/A to $131000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $131000.0, marking a year-over-year change of. This contributed to the annual value of $34000.0 for FY2024, which is N/A changed from last year.
- Per Arbutus Biopharma's latest filing, its Other Non-Current Assets stood at $131000.0 for Q3 2025.
- Over the past 5 years, Arbutus Biopharma's Other Non-Current Assets peaked at $190000.0 during Q1 2022, and registered a low of $3000.0 during Q3 2023.
- Over the past 5 years, Arbutus Biopharma's median Other Non-Current Assets value was $62000.0 (recorded in 2023), while the average stood at $88727.3.
- Per our database at Business Quant, Arbutus Biopharma's Other Non-Current Assets skyrocketed by 6885.25% in 2022 and then plummeted by 9820.36% in 2023.
- Over the past 5 years, Arbutus Biopharma's Other Non-Current Assets (Quarter) stood at $61000.0 in 2021, then soared by 68.85% to $103000.0 in 2022, then crashed by 97.09% to $3000.0 in 2023, then soared by 1033.33% to $34000.0 in 2024, then surged by 285.29% to $131000.0 in 2025.
- Its Other Non-Current Assets stands at $131000.0 for Q3 2025, versus $34000.0 for Q1 2025 and $34000.0 for Q4 2024.